TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20418370

Group type: EXPERIMENTAL
Intervention: tiotropium 18 microg/d
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: budesonide/formoterol 200/6 2 puffs bid
Number of subjects: 19

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 19
Study: 18922425

Group type: EXPERIMENTAL
Intervention: Levosimendan infusion (0.2 microg/kg/min) for 24 hours
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Levosimendan infusion
Number of subjects: 24
Study: 15618526

Group type: EXPERIMENTAL
Intervention: New treatment group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 0
Study: 12814378

Group type: EXPERIMENTAL
Intervention: Real rTMS (20 Hz)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Real rTMS (5 consecutive sessions)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Real rTMS
Number of subjects: 12

Group type: COMPARATOR
Intervention: Real rTMS and Sham rTMS
Number of subjects: 12
Study: 10567289

Group type: EXPERIMENTAL
Intervention: Prophylactic insertion of an implantable cardioverter-defibrillator
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Preoperative symptomatic heart failure (NYHA class I to IV)
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Reoperation
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: History of stroke
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: NYHA class severity
Number of subjects: 900
Study: 9590840

Group type: EXPERIMENTAL
Intervention: 1% miconazole suspension
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Imidazole mixed oil (econazole and miconazole in castor oil)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Dusting mixed imidazole powder onto focal corneal lesions
Number of subjects: 73

Group type: COMPARATOR
Intervention: Focal corneal lesion resection combined with dusting mixed imidazole powder
Number of subjects: 73
Study: 1747568

Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate (ND; 50 mg IM every three weeks)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group 1 (CST therapy for less years)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group 2 (pair-matched control)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate (ND)
Number of subjects: 35
Study: 31684914

Group type: EXPERIMENTAL
Intervention: Dog acquisition group (n=17)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Lagged control group (n=29)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Community control group (n=25)
Number of subjects: 71
Study: 28089425

Group type: EXPERIMENTAL
Intervention: Laryngeal Tube (LT)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway Supreme
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway I‐Gel
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway Unique
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway Aura‐once
Number of subjects: 52
Study: 26041559

Group type: EXPERIMENTAL
Intervention: Robotic surgery
Number of subjects: 244

Group type: COMPARATOR
Intervention: Laparoscopic surgery
Number of subjects: 244
Study: 24063835

Group type: EXPERIMENTAL
Intervention: Triple antiplatelet therapy (aspirin, clopidogrel, and cilostazol); n = 700
Number of subjects: 1399

Group type: COMPARATOR
Intervention: Dual antiplatelet therapy (aspirin and clopidogrel); n = 699
Number of subjects: 1399
Study: 20837822

Group type: EXPERIMENTAL
Intervention: FDG-PET imaging during resting state
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: FDG-PET imaging during memory encoding task
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: HOMA-IR correlation with CMRglu values
Number of subjects: 29
Study: 19691668

Group type: EXPERIMENTAL
Intervention: Viusid (three sachets daily) with hypocaloric diet and aerobic exercise
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (hypocaloric diet and exercise)
Number of subjects: 60
Study: 17537781

Group type: EXPERIMENTAL
Intervention: Levonorgestrel (1.5 mg)
Number of subjects: 15
Study: 14998842

Group type: EXPERIMENTAL
Intervention: gemcitabine plus irinotecan
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: gemcitabine plus docetaxel
Number of subjects: 80
Study: 11452247

Group type: EXPERIMENTAL
Intervention: Sirolimus
Number of subjects: 1336

Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 1336
Study: 10182433

Group type: EXPERIMENTAL
Intervention: 10-week broad-spectrum intervention for bereaved parents
Number of subjects: 0
Study: 8018787

Group type: EXPERIMENTAL
Intervention: Illumination exposure
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: CES-D depression score
Number of subjects: 106
Study: 2916469

Group type: EXPERIMENTAL
Intervention: Bioactivator only
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Bioactivator plus headgear
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (untreated subjects)
Number of subjects: 76
Study: 821675

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 5
Study: 29430998

Group type: EXPERIMENTAL
Intervention: Multidimensional memory program
Number of subjects: 67

Group type: COMPARATOR
Intervention: No-contact control group
Number of subjects: 67
Study: 28138980

Group type: EXPERIMENTAL
Intervention: Once-daily dosing of canagliflozin
Number of subjects: 1347

Group type: EXPERIMENTAL
Intervention: Twice-daily dosing of canagliflozin
Number of subjects: 1347

Group type: COMPARATOR
Intervention: Canagliflozin (both dosing regimens)
Number of subjects: 1347
Study: 25212474

Group type: EXPERIMENTAL
Intervention: Educational intervention with face-to-face teaching
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Educational intervention without face-to-face teaching
Number of subjects: 162

Group type: COMPARATOR
Intervention: Routine care (Control group)
Number of subjects: 162
Study: 23351269

Group type: EXPERIMENTAL
Intervention: Intervention hospitals (based on maternal death review)
Number of subjects: 658

Group type: COMPARATOR
Intervention: Control hospitals
Number of subjects: 658

Group type: EXPERIMENTAL
Intervention: Intervention hospitals (after adjustment)
Number of subjects: 658
Study: 21736448

Group type: EXPERIMENTAL
Intervention: Intravenous (i.v.) administration of erythropoietin (EPO) for 4 months
Number of subjects: 145

Group type: COMPARATOR
Intervention: Subcutaneous (s.c.) administration of erythropoietin (EPO) for 4 months
Number of subjects: 145
Study: 18443671

Group type: EXPERIMENTAL
Intervention: CR tramadol (150 mg daily, titrated to a maximum of 400 mg once daily)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: CR tramadol
Number of subjects: 100
Study: 16869001

Group type: EXPERIMENTAL
Intervention: ABN912
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 12493646

Group type: EXPERIMENTAL
Intervention: High tidal volume mechanical ventilation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low tidal volume mechanical ventilation
Number of subjects: 0
Study: 10638884

Group type: EXPERIMENTAL
Intervention: Maximal bilevel training (45 minutes daily, 5 days a week for 6 weeks, working 2.03+/‐0.4 kJ/kg per session)
Number of subjects: 13

Group type: COMPARATOR
Intervention: O2 cart pushers (45 minutes daily, 5 days a week for 6 weeks, working 1.44+/‐.35 kJ/kg per session)
Number of subjects: 13
Study: 9338536

Group type: EXPERIMENTAL
Intervention: Prophylactic inhaled steroids
Number of subjects: 24
Study: 1524961

Group type: EXPERIMENTAL
Intervention: Plain prednisolone tablets (30 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Enteric-coated prednisolone tablets (30 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Plain and enteric-coated prednisolone tablets (30 mg)
Number of subjects: 16
Study: 3156329

Group type: EXPERIMENTAL
Intervention: Bolus intravenous injection of fibronectin (1 mg/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Bolus injection of one-half of the dose followed by continuous infusion of the remaining half-dose over a 6-hour period (group B + P)
Number of subjects: 10
Study: 29485234

Group type: EXPERIMENTAL
Intervention: Ionization
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Wood shavings and haylage
Number of subjects: 24

Group type: COMPARATOR
Intervention: Straw and dry hay
Number of subjects: 24
Study: 27159166

Group type: EXPERIMENTAL
Intervention: Intramuscular (IM) immunization with CN54 gp140 at 20 or 100 μg co-administered with Glucopyranosyl Lipid Adjuvant (GLA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intranasal (IN) immunization with CN54 gp140 and 0.5% chitosan
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravaginal (IVAG) immunization with CN54 gp140 in an aqueous gel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intramuscular (IM) boosting after IN priming
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IM groups
Number of subjects: 0
Study: 24107072

Group type: EXPERIMENTAL
Intervention: GSK2336805 + PEG/RIBA
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo + PEG/RIBA
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: GSK2336805 (monotherapy)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (monotherapy)
Number of subjects: 16
Study: 22784346

Group type: EXPERIMENTAL
Intervention: Sahaja yoga meditation
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (Mahatma Gandhi Mission Hospital treatment)
Number of subjects: 67
Study: 20833796

Group type: EXPERIMENTAL
Intervention: High dose of alcohol (target BAC = .10%)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No alcohol
Number of subjects: 0
Study: 18231713

Group type: EXPERIMENTAL
Intervention: Sodium valproate (VPA)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 16164447

Group type: EXPERIMENTAL
Intervention: salbutamol (5 mg/mL)
Number of subjects: 9

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 9
Study: 12753877

Group type: EXPERIMENTAL
Intervention: Tramadol/acetaminophen combination tablets (37.5 mg tramadol/325 mg acetaminophen)
Number of subjects: 315
Study: 11103223

Group type: EXPERIMENTAL
Intervention: High-fat lunch
Number of subjects: 15

Group type: COMPARATOR
Intervention: High-carbohydrate lunch
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: High-fat snack
Number of subjects: 15

Group type: COMPARATOR
Intervention: High-carbohydrate snack
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Overall high-fat foods
Number of subjects: 15

Group type: COMPARATOR
Intervention: Overall high-carbohydrate foods
Number of subjects: 15
Study: 8972812

Group type: EXPERIMENTAL
Intervention: Continuous arch wire technique (CAW)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Segmented arch technique (Burstone)
Number of subjects: 50
Study: 1480305

Group type: EXPERIMENTAL
Intervention: Testosterone propionate 2%
Number of subjects: 40

Group type: COMPARATOR
Intervention: Clobetasol dipropionate 0.05%
Number of subjects: 40
Study: 3001925

Group type: EXPERIMENTAL
Intervention: Low-fibre diet
Number of subjects: 95

Group type: COMPARATOR
Intervention: Unrestricted diet
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Three end-expiratory breath hydrogen sampling methods
Number of subjects: 95
Study: 30658677

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 29202850

Group type: EXPERIMENTAL
Intervention: Small Changes (reduce calorie intake by 100 kcals/day & add 2000 steps/day)
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Large Changes (lose 2.3-4.5 kg initially & increase PA to ≥250 min/wk)
Number of subjects: 599

Group type: COMPARATOR
Intervention: Self-guided (control condition)
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: All groups combined
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: ≥250 min/wk. of MVPA
Number of subjects: 599
Study: 26057780

Group type: EXPERIMENTAL
Intervention: Mixture of pure platelet concentrate and deproteinized bovine bone mineral (test group)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Deproteinized bovine bone (control group)
Number of subjects: 6
Study: 23441841

Group type: EXPERIMENTAL
Intervention: Berberine 500 mg twice a day for 3 months
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Berberine after washout period
Number of subjects: 144
Study: 21517964

Group type: EXPERIMENTAL
Intervention: PCV7 vaccination
Number of subjects: 96
Study: 19375278

Group type: EXPERIMENTAL
Intervention: Contrast baths with exercise
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Contrast baths without exercise
Number of subjects: 114

Group type: COMPARATOR
Intervention: Exercise-only control treatment
Number of subjects: 114
Study: 16931635

Group type: EXPERIMENTAL
Intervention: Single-nucleotide polymorphism +79 in African Americans
Number of subjects: 669

Group type: EXPERIMENTAL
Intervention: Haplotype association in African Americans
Number of subjects: 669

Group type: EXPERIMENTAL
Intervention: Poly-C repeat (+1269) in ADRβ2
Number of subjects: 669
Study: 15298636

Group type: EXPERIMENTAL
Intervention: Omeprazole 80 mg/day
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study: 11495220

Group type: EXPERIMENTAL
Intervention: Low-fat, high-fiber, high-fruit/vegetable diet (20% of energy from fat, 18 g/1,000 kcal/day fiber, 3.5 servings/1,000 kcal/day fruit/vegetable)
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Low-fat, high-fiber, high-fruit/vegetable diet
Number of subjects: 394

Group type: COMPARATOR
Intervention: Control group (standard diet)
Number of subjects: 394
Study: 10101924

Group type: EXPERIMENTAL
Intervention: Children with newly diagnosed diabetes type 1 who were fed mother's milk (n=19)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Children with newly diagnosed diabetes type 1 who were fed artificially (n=26)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Healthy children (n=65)
Number of subjects: 142
Study: 7812890

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium 2% eye drops, administered twice daily for 4 weeks
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study: 3235806

Group type: EXPERIMENTAL
Intervention: Sterile technique for preparation of the skin over the vascular access site
Number of subjects: 71

Group type: COMPARATOR
Intervention: Clean technique for preparation of the skin over the vascular access site
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Overall infection rate
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Vascular access-site infection rate
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Bacteremia rate
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Risk factors for infections
Number of subjects: 71
Study: 31425454

Group type: EXPERIMENTAL
Intervention: Nordic hamstrings exercise (NHE)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Eccentric leg curl (ELC)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 25
Study: 31406294

Group type: EXPERIMENTAL
Intervention: Mailed letter intervention
Number of subjects: 228000

Group type: COMPARATOR
Intervention: No letter (control)
Number of subjects: 228000

Group type: EXPERIMENTAL
Intervention: Different versions of letters with behavioural science techniques
Number of subjects: 228000
Study: 28604015

Group type: EXPERIMENTAL
Intervention: HOPES‐I intervention (1 session per week for 9-12 months)
Number of subjects: 47
Study: 26206174

Group type: EXPERIMENTAL
Intervention: Interventions targeting perceived barriers to vegetable intake among boys.
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Higher levels of eating vegetables together with family, previous vegetable intake, and lower perceived barriers.
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Follow-up measures in 2010.
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Lower level of parental demand for children to eat vegetables.
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Gender differences in predictors of liking vegetables.
Number of subjects: 424
Study: 23121256

Group type: EXPERIMENTAL
Intervention: 30% salicylic acid peels
Number of subjects: 13

Group type: COMPARATOR
Intervention: Jessner's solution peels
Number of subjects: 13
Study: 21793631

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 43
Study: 19114895

Group type: EXPERIMENTAL
Intervention: Alkaline phosphatase (AP) treatment
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 16518530

Group type: EXPERIMENTAL
Intervention: 40 mg atorvastatin
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: 40 mg simvastatin
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study: 12774876

Group type: EXPERIMENTAL
Intervention: Co-bedding
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control (Single-bedding)
Number of subjects: 37
Study: 10699055

Group type: EXPERIMENTAL
Intervention: Individualised genetic assessment, genetic counselling, and gene testing (where appropriate) added to typical advice and surveillance from a hospital breast clinic.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Typical advice and surveillance from a hospital breast clinic.
Number of subjects: 0
Study: 9573831

Group type: EXPERIMENTAL
Intervention: Dental laser plus scaling and root planing
Number of subjects: 10

Group type: COMPARATOR
Intervention: Scaling and root planing alone
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control only
Number of subjects: 10
Study: 8400973

Group type: EXPERIMENTAL
Intervention: Metoprolol 50‐100 mg twice daily
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Isradipine 2.5‐5.0 mg twice daily
Number of subjects: 42

Group type: COMPARATOR
Intervention: Calcium entry blockers
Number of subjects: 42

Group type: COMPARATOR
Intervention: Beta blockers
Number of subjects: 42
Study: 3037934

Group type: EXPERIMENTAL
Intervention: Halothane anesthesia
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Enflurane anesthesia
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Isoflurane anesthesia
Number of subjects: 30

Group type: COMPARATOR
Intervention: Halothane, Enflurane, Isoflurane
Number of subjects: 30
Study: 29094444

Group type: EXPERIMENTAL
Intervention: Metformin (MTF) 1700 mg/day
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study: 26847305

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided steroid injection into scalene muscles
Number of subjects: 20

Group type: COMPARATOR
Intervention: Stretching exercise only
Number of subjects: 20
Study: 24802775

Group type: EXPERIMENTAL
Intervention: Avatrombopag 2.5 mg
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Avatrombopag 5 mg
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Avatrombopag 10 mg
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Avatrombopag 20 mg
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Avatrombopag (all doses)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Avatrombopag
Number of subjects: 64
Study: 22508732

Group type: EXPERIMENTAL
Intervention: Epidural steroids
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 84

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 84
Study: 20187286

Group type: EXPERIMENTAL
Intervention: Resistance respiratory muscle training (RRMT) performed every 30 s against spring loaded inspiratory and expiratory valves 30 min/day, 5 days/week, for 4 weeks.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Resistance respiratory muscle training (RRMT)
Number of subjects: 8
Study: 18853581

Group type: EXPERIMENTAL
Intervention: Isotonic sodium bicarbonate
Number of subjects: 0
Study: 16848109

Group type: EXPERIMENTAL
Intervention: Pasteurized cow milk yogurt (15 ml/kg/day) plus routine hospital treatment
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine hospital treatment
Number of subjects: 80
Study: 14685931

Group type: EXPERIMENTAL
Intervention: LI4 and BL67 acupressure
Number of subjects: 127

Group type: COMPARATOR
Intervention: Light skin stroking
Number of subjects: 127

Group type: COMPARATOR
Intervention: No treatment/conversation only
Number of subjects: 127
Study: 10973843

Group type: EXPERIMENTAL
Intervention: Active treatment (nitrendipine, with possible addition of enalapril, hydrochlorothiazide, or both)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Active treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9261659

Group type: EXPERIMENTAL
Intervention: Initial binge eating
Number of subjects: 108

Group type: COMPARATOR
Intervention: Initial dieting
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Initial binge eaters
Number of subjects: 108
Study: 8451663

Group type: EXPERIMENTAL
Intervention: Two-component acellular pertussis vaccine (LPF/FHA)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Standard whole-cell pertussis vaccine
Number of subjects: 145
Study: 2434108

Group type: EXPERIMENTAL
Intervention: Intravenously administered human pepsinated immunoglobulin G (HPIG, Gamma‐Venin)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified what treatment or intervention was used)
Number of subjects: 0
Study: 30259623

Group type: EXPERIMENTAL
Intervention: Exenatide 2.5 mcg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 6
Study: 28845751

Group type: EXPERIMENTAL
Intervention: Canakinumab 50 mg
Number of subjects: 10061

Group type: EXPERIMENTAL
Intervention: Canakinumab 150 mg
Number of subjects: 10061

Group type: EXPERIMENTAL
Intervention: Canakinumab 300 mg
Number of subjects: 10061

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10061
Study: 25796269

Group type: EXPERIMENTAL
Intervention: Integrated tobacco control and occupational safety and health program
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control companies
Number of subjects: 20
Study: 23462720

Group type: EXPERIMENTAL
Intervention: Intraperitoneal (IP) chemotherapy with cisplatin and paclitaxel
Number of subjects: 393

Group type: COMPARATOR
Intervention: Intravenous (IV) chemotherapy with paclitaxel and cisplatin
Number of subjects: 393
Study: 21289328

Group type: EXPERIMENTAL
Intervention: Tolvaptan
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tolvaptan (in patients with serum sodium concentration of <130 meq/L)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (in hyponatremic patients)
Number of subjects: 0

Group type: COMPARATOR
Intervention: More severely hyponatremic patients (serum sodium concentration of <135 meq/L) receiving placebo
Number of subjects: 0